Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study
Authors:
- Andrew M. TonkinATAndrew M. Tonkin
- Simon EckermannSESimon Eckermann
- Harvey WhiteHWHarvey White
- Denis FriedlanderDFDenis Friedlander
- Paul GlasziouPGPaul Glasziou
- Paul MagnusPMPaul Magnus
- Adrienne KirbyAKAdrienne Kirby
- Sarah MulraySMSarah Mulray
- Mary DentonMDMary Denton
- Michele SallabergerMSMichele Sallaberger
- David HuntDHDavid Hunt
- John SimesJSJohn Simes
- 1 June 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 151 (6) , 1305-1312
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Lipid-Lowering Therapy With Statins in High-Risk Elderly PatientsJAMA, 2004
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Low prevalence of lipid lowering drug use in older men with established coronary heart diseaseHeart, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-upThe Lancet, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectorisThe American Journal of Cardiology, 1995